MARC Record from marc_columbia

LEADER: 04526fam a2200469 a 4500
001 4051738
005 20221027024751.0
008 960305t19961996nyua 001 0 eng c
010 $a 96007342
020 $a0824793021 (hardcover : alk. paper)
035 $a(OCoLC)34474642
035 $a(OCoLC)ocm34474642
035 $9ALN7910HS
035 $a(NNC)4051738
035 $a4051738
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB-B
050 00 $aRM333.5$b.S46 1996
060 10 $aW1 ME421SM v.3 1996$aQV 126 S4853 1996
082 00 $a616.89/18$220
245 00 $aSerotonin in antipsychotic treatment :$bmechanisms and clinical practice /$cedited by John M. Kane, H.-J. Möller, Frans Awouters.
260 $aNew York :$bM. Dekker,$c[1996], ©1996.
300 $axiv, 388 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aMedical psychiatry ;$v3
500 $aIncludes index.
505 00 $tIntroduction /$rWilliam A. Frosch --$g1.$tThe Treatment of Psychotic Disorders: The Search for Effective and Safe Long-Term Treatment /$rJohn M. Kane --$g2.$tOngoing Research in the Treatment of Schizophrenia /$rDonna Ames, Stephen R. Marder, William C. Wirshing and Theodore Van Putten --$g3.$tHistory of Antidopaminergic Neuroleptics /$rAlistair Munro and Patrick Flynn --$g4.$tSerotonin Receptor Subtypes: Possible Roles and Implications in Antipsychotic Drug Action /$rJosee E. Leysen, Walter Gommeren and Alain Schotte --$g5.$tThe Role of Serotonin in Schizophrenia and the Mechanism of Action of Antipsychotic Drugs /$rHerbert Y. Meltzer and S. Hossein Fatemi --$g6.$tSerotonin Mechanisms in Antipsychotic Treatment: Evidence from Drug Discrimination Studies /$rTheo F. Meert --$g7.$tDopamine, Serotonin, and Their Interactions in Schizophrenia /$rRene S. Kahn and Herman M. Van Praag --
505 80 $g8.$tChemistry and Pharmacology of Drugs Acting on Both 5HT[subscript 2]- and D[subscript 2]-Receptors /$rAnton A. H. P. Megens, Ludo Kennis, Jan Vandenberk and Frans Awouters --$g9.$tPositron Emission Tomography Studies of 5HT[subscript 2]-Receptors /$rSvante Nyberg, Anna-Lena Nordstrom, Christer Halldin and Lars Farde --$g10.$tAssessment of Negative Symptoms: Development of the PANSS /$rLewis A. Opler --$g11.$tBiochemical Markers for Negative Symptoms in Schizophrenia /$rDavid F. Horrobin and A. Iain M. Glen --$g12.$tUnderstanding the Relationship Between Extrapyramidal Side Effects and Tardive Dyskinesia /$rDaniel S. G. Umbricht and John M. Kane --$g13.$tRisperidone: An Overview of Animal Pharmacology, Toxicology, and Pharmacokinetics /$rHerman Van Cauteren, Anton A. H. P. Megens, Ann Lampo and Willem Meuldermans --$g14.$tClinical Pharmacokinetics of Risperidone /$rAchiel Van Peer, Willem Meuldermans, Robert Woestenborghs and Jos Heykants --
505 80 $g15.$tThe Clinical Development of Risperidone /$rRichard C. Meibach and Stef L. E. Heylen --$g16.$tThe Treatment of Schizophrenia: Comparative Studies with Placebo, Haloperidol, and Risperidone /$rAnn Mortimer and Thomas R. E. Barnes --$g17.$tRisperidone in Comparison with Various Treatments of Schizophrenia /$rEckhard Klieser, Erlo Lehmann and Kurt Heinrich --$g18.$tExtrapyramidal Side Effects of Neuroleptic Medication: Focus on Risperidone /$rH.-J. Moller --$g19.$tGuidelines for the Practical Use of Risperidone /$rTerence M. Reilly and Stef L. E. Heylen.
650 0 $aAntipsychotic drugs.$0http://id.loc.gov/authorities/subjects/sh89002390
650 0 $aSerotonin$xAntagonists.$0http://id.loc.gov/authorities/subjects/sh85120302
650 0 $aSchizophrenia$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh85118163
650 12 $aSerotonin$xphysiology.$0https://id.nlm.nih.gov/mesh/D012701Q000502
650 22 $aReceptors, Serotonin$xdrug effects.$0https://id.nlm.nih.gov/mesh/D011985Q000187
650 22 $aAntipsychotic Agents$xpharmacology.$0https://id.nlm.nih.gov/mesh/D014150Q000494
650 22 $aPsychotic Disorders$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D011618Q000188
650 22 $aSchizophrenia$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D012559Q000188
700 1 $aKane, John M.,$d1945-$0http://id.loc.gov/authorities/names/n84045058
700 1 $aMöller, Hans-Jürgen.$0http://id.loc.gov/authorities/names/n81063489
700 1 $aAwouters, Frans,$d1937-$0http://id.loc.gov/authorities/names/n96800782
830 0 $aMedical psychiatry ;$v3.$0http://id.loc.gov/authorities/names/n86723649
852 00 $boff,hsl$hRM333.5$i.S46 1996